Wolfgang Schütte
165 works · 1,943 citations · h-index 16
Top works
- Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
- Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
- FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
- KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
- Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer
- Behandlung der respiratorischen Papillomatose – Kasuistik zur systemischen Therapie mit Bevacizumab
- Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation
- Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
- Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS)
- Blood immune cell biomarkers in lung cancer
- Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
- Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer
- 1364P Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
- Survival of Hypercapnic Patients with COPD and Obesity Hypoventilation Syndrome Treated with High Intensity Non Invasive Ventilation in the Daily Routine Care
- Topotecan in the Therapy of Brain Metastases in Lung Cancer
- Efficacy, safety and predictive biomarker results from OAK, a randomized phase III study comparing atezolizumab with docetaxel in patients with advanced NSCLC
- Rehabilitationsrecht
- Gemeinsame Stellungnahme der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Röntgengesellschaft zur Lungenkrebsfrüherkennung mit Niedrigdosis-CT
- Lung Cancer in Germany
- Empfehlung der Sektionen 2 und 11 der DGP zur Rebiopsie bei Lungenkarzinomen